Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer
- PMID: 19185836
- DOI: 10.1016/S1470-2045(09)70020-8
Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer
Abstract
The incidence of differentiated thyroid carcinoma (DTC) is increasing in most developed countries. The only well-known risk factor for thyroid cancer is exposure to ionising radiation. DTC is characterised by a strong hereditability, and individual susceptibility is likely due to genetic factors modulating the environmental risk. Identification of genetic polymorphisms is important for understanding the potential mechanisms involved in thyroid carcinogenesis. In this Review, we assess epidemiological data on the role of germ-line DNA polymorphisms and the risk of DTC. We have included only case-control studies that compare the incidence of germ-line mutations in patients with DTC, with the incidence of mutations in patients without a history of DTC. Such an analysis of genetic susceptibility in differentiated thyroid cancer has not yet been published.
Similar articles
-
The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.Oncol Rep. 2013 Nov;30(5):2458-66. doi: 10.3892/or.2013.2702. Epub 2013 Aug 27. Oncol Rep. 2013. PMID: 23982724
-
Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.Laryngoscope. 2005 Jun;115(6):938-45. doi: 10.1097/01.MLG.0000163765.88158.86. Laryngoscope. 2005. PMID: 15933498
-
Genetic susceptibility to radiation-related differentiated thyroid cancers: a systematic review of literature.Endocr Relat Cancer. 2019 Oct;26(10):R583-R596. doi: 10.1530/ERC-19-0321. Endocr Relat Cancer. 2019. PMID: 31476737
-
Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):756-61. doi: 10.1001/archotol.132.7.756. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16847185
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
Cited by
-
TGF-β1-509C/T polymorphism and the risk of ESCC in a Chinese Han population.Int J Clin Exp Med. 2015 Jul 15;8(7):11524-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379974 Free PMC article.
-
Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.Medicine (Baltimore). 2015 Sep;94(38):e1536. doi: 10.1097/MD.0000000000001536. Medicine (Baltimore). 2015. PMID: 26402809 Free PMC article.
-
Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.PLoS One. 2014 Oct 17;9(10):e109822. doi: 10.1371/journal.pone.0109822. eCollection 2014. PLoS One. 2014. PMID: 25330015 Free PMC article.
-
Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area.Eur J Nutr. 2017 Apr;56(3):965-971. doi: 10.1007/s00394-015-1144-2. Epub 2016 Jan 8. Eur J Nutr. 2017. PMID: 26746218
-
The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.Iran Biomed J. 2012;16(4):218-22. doi: 10.6091/ibj.1078.2012. Iran Biomed J. 2012. PMID: 23183621 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical